Lu Ting, Wang Yao, Dou Ting, Xue Bizhen, Tan Yuanyuan, Yang Jiao
Department of Endocrinology, Zhongda Hospital, Institute of Diabetes, Medical School, Southeast University, Jiangsu, China.
Department of Endocrinology, the Affiliated Yixing Hospital of Jiangsu University, Yixing, Jiangsu, China.
Endocr J. 2019 Mar 28;66(3):265-270. doi: 10.1507/endocrj.EJ18-0436. Epub 2019 Jan 30.
The pathogenesis of type 2 diabetes mellitus (T2DM) is characterized by insulin resistance and β-cell dysfunction. Earlier studies reported that increased levels of pancreatic fat may lead to the development of β-cell dysfunction and insulin resistance. The present study aimed to demonstrate the relationship between pancreatic fat content (PFC) and insulin secretion and insulin resistance in Chinese subjects with T2DM. Seventy-eight T2DM subjects and 35 non-diabetic volunteers were recruited in this study. All subjects were subjected to an oral glucose tolerance test (OGTT). We also measured PFC and liver fat content (LFC) by three-point Dixon method (3p-Dixon), and we examined the relations between PFC and OGTT-derived parameters. T2DM subjects had higher PFC than non-diabetic subjects (p < 0.01). PFC was correlated with body mass index (BMI), liver fat content (LFC) and age in two groups, however, it was only positively associated with insulin secretion, insulin resistance, early- and late-phase insulin secretion in male T2DM subjects, but not in non-diabetic and female T2DM subjects. After adjusting for BMI, LFC and age, the association still existed (all p < 0.05). Furthermore, the relationship was more obvious in male T2DM subjects with a shorter course of disease. PFC was associated with β-cell dysfunction and insulin resistance in subjects with T2DM and was more obvious in male T2DM subjects with shorter duration of diabetes. Therefore, PFC might represent a potential risk factor for the development of T2DM.
2型糖尿病(T2DM)的发病机制以胰岛素抵抗和β细胞功能障碍为特征。早期研究报道,胰腺脂肪水平升高可能导致β细胞功能障碍和胰岛素抵抗的发生。本研究旨在阐明中国T2DM患者的胰腺脂肪含量(PFC)与胰岛素分泌及胰岛素抵抗之间的关系。本研究招募了78例T2DM患者和35名非糖尿病志愿者。所有受试者均接受口服葡萄糖耐量试验(OGTT)。我们还采用三点Dixon法(3p-Dixon)测量了PFC和肝脏脂肪含量(LFC),并研究了PFC与OGTT衍生参数之间的关系。T2DM患者的PFC高于非糖尿病患者(p<0.01)。两组中PFC均与体重指数(BMI)、肝脏脂肪含量(LFC)和年龄相关,然而,仅在男性T2DM患者中,PFC与胰岛素分泌、胰岛素抵抗、早期和晚期胰岛素分泌呈正相关,在非糖尿病患者和女性T2DM患者中则不然。在调整BMI、LFC和年龄后,这种关联仍然存在(所有p<0.05)。此外,在病程较短的男性T2DM患者中这种关系更为明显。PFC与T2DM患者的β细胞功能障碍和胰岛素抵抗相关,且在糖尿病病程较短的男性T2DM患者中更为明显。因此,PFC可能是T2DM发生的一个潜在危险因素。